Thursday 25 September 2014

Optical imaging would make disease diagnose effective in the future

As per a new report by Allied Market Research titled, “Optical Imaging Market - Industry Overview, Size, Growth, Analysis, Global Share, Trends Opportunities and Forecast 2012 - 2020” the global optical imaging market was valued at $915.75 million in 2012 and is expected to register a CAGR of 12.2% by 2020.

Optical imaging is an upcoming and rapidly growing imaging technique which is used mainly in the medical offices. It helps in improving diseases diagnosis, treatment and prevention. It enables accurate and proper viewing of body organs, even molecules and also tissues.

The report by Allied Market Research provides extensive knowledge on the global optical imaging market including the latest market trends, growth factors, market size & forecasts, etc. The market includes Near-Infrared Spectroscopy (NIRS), Photo-Acoustic Tomography (PAT), Hyper-Spectral Imaging (HSI) and Optical Coherence Tomography (OCT).

To Get Full Access of the report visit http://www.alliedmarketresearch.com/optical-imaging-market

Growing health concerns is driving the market growth. It’s a no ionization and non-invasive technique of imaging which allows higher safety and efficiency to track any progressive disease.

The only restraint for the market is the expensive investment in installing this technique. However, the price has little effect on the growth of the global market. With the increased incidences of chronic diseases like cancer and medical awareness, Asia-Pacific market is expected to register a significant growth rate. North America leads the global market followed by Europe.

Prominent player profiled in the report are Michelson Diagnostics, Volcano Corporation, Carl Zeiss Meditec, Chemlmage Corporation, Headwall Photonics, Somanetics Corporation, ASE Optics Inc., Topcon Medical Systems Inc and Bioptigen Inc.